Examination of glucose transporter-1, transforming growth factor-β and neuroglobin immunoreactivity in the orbitofrontal cortex in late-life depression.

  1. Lookup NU author(s)
  2. Dr Ahmad Khundakar
  3. Louise Ward
  4. Janet Slade
  5. Professor Alan Thomas
Author(s)Khundakar A, Morris C, Slade J, Thomas AJ
Publication type Article
JournalPsychiatry and Clinical Neuroscience
ISSN (print)1323-1316
ISSN (electronic)1440-1819
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Aims: This study immunohistochemically examined the orbitofrontal cortex for three possible candidates in hypoxic/ischemic signaling: the cytokine transforming growth factor-β, the glucose transporter-1 and the neuron-specific oxygen-binding protein neuroglobin. Methods: Post-mortem tissue from 20 depressed and 20 non-depressed individuals was obtained and the expression of the three proteins was analyzed using image analysis software. Results: No significant changes were found in transforming growth factor-β or neuroglobin in the orbitofrontal cortex between depressed and non-depressed individuals. There was, however, a trend towards a reduction in glucose transporter-1 in the depressed group. Conclusions: This study does not clearly support the hypothesis that hypoxic/ischemic processes are behind the pathological deficits in the frontal-subcortical circuitry associated with depression and therefore does not provide evidence to support the 'vascular depression' hypothesis.
PublisherWiley-Blackwell Publishing Asia
PubMed id21232076
Actions    Link to this publication

Altmetrics provided by Altmetric